                         SEQUENCE LISTING

<110>  Sanofi-Aventis Deutschland GmbH
 
<120>  Synthesis of cyclic imide containing peptide products

<130>  55130P EP

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Lixisenatide GLP-1 agonist

<400>  1

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Ser Lys Lys Lys Lys Lys Lys 
        35                  40                  


